Why the study?
Does the determination of serum glutamic oxalacetic transaminase levels aid in differentiating myocardial infarction from pulmonary infarction or embolism?
Population
Patients with suspected myocardial infarction or pulmonary infarction/embolism
Design
Editorial
Authors
Loading...
Serum glutamic oxalacetic transaminase is a useful but time-limited biomarker for diagnosing myocardial infarction.
Does the determination of serum glutamic oxalacetic transaminase levels aid in differentiating myocardial infarction from pulmonary infarction or embolism?
Serum glutamic oxalacetic transaminase is a useful but time-limited biomarker for diagnosing myocardial infarction.
Laurens P. White (1956) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: